vs

Side-by-side financial comparison of PETMED EXPRESS INC (PETS) and TEJON RANCH CO (TRC). Click either name above to swap in a different company.

PETMED EXPRESS INC is the larger business by last-quarter revenue ($40.7M vs $21.1M, roughly 1.9× TEJON RANCH CO). TEJON RANCH CO runs the higher net margin — 7.5% vs -26.0%, a 33.4% gap on every dollar of revenue. On growth, TEJON RANCH CO posted the faster year-over-year revenue change (17.7% vs -23.3%). Over the past eight quarters, TEJON RANCH CO's revenue compounded faster (68.8% CAGR vs -20.9%).

PetMed Express, Inc., also known as PetMeds, is an online pet pharmacy based in the United States. It is publicly traded and sells prescription and non-prescription pet medication.

Tejon Ranch Company, based in Lebec, California, is one of the largest private landowners in California. The company was incorporated in 1936 to organize the ownership of a large tract of land that was consolidated from four Mexican land grants acquired in the 1850s and 1860s by ranch founder Edward Fitzgerald Beale.

PETS vs TRC — Head-to-Head

Bigger by revenue
PETS
PETS
1.9× larger
PETS
$40.7M
$21.1M
TRC
Growing faster (revenue YoY)
TRC
TRC
+40.9% gap
TRC
17.7%
-23.3%
PETS
Higher net margin
TRC
TRC
33.4% more per $
TRC
7.5%
-26.0%
PETS
Faster 2-yr revenue CAGR
TRC
TRC
Annualised
TRC
68.8%
-20.9%
PETS

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
PETS
PETS
TRC
TRC
Revenue
$40.7M
$21.1M
Net Profit
$-10.6M
$1.6M
Gross Margin
23.3%
30.6%
Operating Margin
-25.7%
10.9%
Net Margin
-26.0%
7.5%
Revenue YoY
-23.3%
17.7%
Net Profit YoY
-1392.6%
-64.7%
EPS (diluted)
$-0.50
$0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PETS
PETS
TRC
TRC
Q4 25
$40.7M
$21.1M
Q3 25
$44.4M
$12.0M
Q2 25
$51.2M
$8.3M
Q1 25
$50.8M
$8.2M
Q4 24
$52.0M
$17.9M
Q3 24
$58.0M
$10.9M
Q2 24
$66.2M
$5.7M
Q1 24
$65.1M
$7.4M
Net Profit
PETS
PETS
TRC
TRC
Q4 25
$-10.6M
$1.6M
Q3 25
$-8.5M
$1.7M
Q2 25
$-34.2M
$-1.7M
Q1 25
$-11.6M
$-1.5M
Q4 24
$-707.0K
$4.5M
Q3 24
$2.3M
$-1.8M
Q2 24
$3.8M
$957.0K
Q1 24
$-5.0M
$-914.0K
Gross Margin
PETS
PETS
TRC
TRC
Q4 25
23.3%
30.6%
Q3 25
28.0%
28.4%
Q2 25
28.1%
40.9%
Q1 25
29.9%
15.0%
Q4 24
31.0%
42.9%
Q3 24
32.3%
22.9%
Q2 24
28.8%
45.3%
Q1 24
29.3%
0.3%
Operating Margin
PETS
PETS
TRC
TRC
Q4 25
-25.7%
10.9%
Q3 25
-18.9%
-16.9%
Q2 25
-66.7%
-48.8%
Q1 25
-11.9%
-50.7%
Q4 24
-0.9%
11.9%
Q3 24
1.0%
-34.9%
Q2 24
6.6%
-62.4%
Q1 24
-5.9%
-53.8%
Net Margin
PETS
PETS
TRC
TRC
Q4 25
-26.0%
7.5%
Q3 25
-19.2%
14.0%
Q2 25
-66.7%
-20.6%
Q1 25
-22.9%
-17.8%
Q4 24
-1.4%
25.0%
Q3 24
4.0%
-16.9%
Q2 24
5.7%
16.8%
Q1 24
-7.7%
-12.3%
EPS (diluted)
PETS
PETS
TRC
TRC
Q4 25
$-0.50
$0.05
Q3 25
$-0.41
$0.06
Q2 25
$-1.65
$-0.06
Q1 25
$-0.56
$-0.05
Q4 24
$-0.03
$0.16
Q3 24
$0.11
$-0.07
Q2 24
$0.18
$0.04
Q1 24
$-0.24
$-0.03

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PETS
PETS
TRC
TRC
Cash + ST InvestmentsLiquidity on hand
$26.9M
$9.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$32.8M
$475.2M
Total Assets
$88.0M
$630.5M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PETS
PETS
TRC
TRC
Q4 25
$26.9M
$9.5M
Q3 25
$36.1M
$3.6M
Q2 25
$41.1M
$2.5M
Q1 25
$54.7M
$12.3M
Q4 24
$50.1M
$39.3M
Q3 24
$52.0M
$27.4M
Q2 24
$46.0M
$33.0M
Q1 24
$55.3M
$35.6M
Stockholders' Equity
PETS
PETS
TRC
TRC
Q4 25
$32.8M
$475.2M
Q3 25
$43.1M
$473.2M
Q2 25
$51.5M
$471.5M
Q1 25
$85.1M
$472.5M
Q4 24
$96.2M
$473.6M
Q3 24
$96.4M
$468.3M
Q2 24
$93.5M
$469.2M
Q1 24
$96.7M
$467.4M
Total Assets
PETS
PETS
TRC
TRC
Q4 25
$88.0M
$630.5M
Q3 25
$100.3M
$629.6M
Q2 25
$109.8M
$618.5M
Q1 25
$148.7M
$614.6M
Q4 24
$144.8M
$608.0M
Q3 24
$146.0M
$598.0M
Q2 24
$152.7M
$590.8M
Q1 24
$169.9M
$581.6M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PETS
PETS
TRC
TRC
Operating Cash FlowLast quarter
$-9.2M
$6.1M
Free Cash FlowOCF − Capex
$-9.2M
FCF MarginFCF / Revenue
-22.7%
Capex IntensityCapex / Revenue
0.1%
Cash ConversionOCF / Net Profit
3.88×
TTM Free Cash FlowTrailing 4 quarters
$-23.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PETS
PETS
TRC
TRC
Q4 25
$-9.2M
$6.1M
Q3 25
$-2.2M
$-2.4M
Q2 25
$-12.3M
$-381.0K
Q1 25
$7.0M
$-1.3M
Q4 24
$-1.2M
$14.3M
Q3 24
$7.4M
$2.1M
Q2 24
$-8.5M
$-1.8M
Q1 24
$7.1M
$777.0K
Free Cash Flow
PETS
PETS
TRC
TRC
Q4 25
$-9.2M
Q3 25
$-4.8M
$-14.6M
Q2 25
$-13.6M
$-20.0M
Q1 25
$4.6M
$-18.9M
Q4 24
$-1.9M
$-42.9M
Q3 24
$6.1M
$-16.8M
Q2 24
$-9.2M
$-15.8M
Q1 24
$5.9M
$-7.3M
FCF Margin
PETS
PETS
TRC
TRC
Q4 25
-22.7%
Q3 25
-10.8%
-122.2%
Q2 25
-26.5%
-240.6%
Q1 25
9.1%
-230.1%
Q4 24
-3.7%
-239.3%
Q3 24
10.6%
-155.2%
Q2 24
-13.9%
-277.2%
Q1 24
9.0%
-99.0%
Capex Intensity
PETS
PETS
TRC
TRC
Q4 25
0.1%
Q3 25
5.9%
102.3%
Q2 25
2.5%
236.0%
Q1 25
4.7%
213.7%
Q4 24
1.5%
319.1%
Q3 24
2.2%
174.3%
Q2 24
1.0%
245.5%
Q1 24
1.9%
109.5%
Cash Conversion
PETS
PETS
TRC
TRC
Q4 25
3.88×
Q3 25
-1.43×
Q2 25
Q1 25
Q4 24
3.19×
Q3 24
3.18×
Q2 24
-2.27×
-1.88×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PETS
PETS

Reorder$34.0M84%
New Order$5.0M12%
Membership Fees$1.6M4%

TRC
TRC

Segment breakdown not available.

Related Comparisons